Doximity, Inc.

Informe acción NYSE:DOCS

Capitalización de mercado: US$4.5b

Doximity Dirección

Dirección controles de criterios 4/4

El CEO de Doximity's es Jeff Tangney , nombrado en Apr 2010, tiene una permanencia de 14.08 años. compensación anual total es $243.73K, compuesta por 98.5% salario y 1.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 27.22% de las acciones de la empresa, por valor de $1.23B. La antigüedad media del equipo directivo y de la junta directiva es de 3.3 años y 8.7 años, respectivamente.

Información clave

Jeff Tangney

Chief Executive Officer (CEO)

US$243.7k

Compensación total

Porcentaje del salario del CEO98.5%
Permanencia del CEO14.1yrs
Participación del CEO27.2%
Permanencia media de la dirección3.3yrs
Promedio de permanencia en la Junta Directiva8.7yrs

Actualizaciones recientes de la dirección

Recent updates

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Mar 26
Estimating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

Feb 15
We Like Doximity's (NYSE:DOCS) Earnings For More Than Just Statutory Profit

What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Feb 13
What Is Doximity, Inc.'s (NYSE:DOCS) Share Price Doing?

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Jan 04
Doximity (NYSE:DOCS) May Have Issues Allocating Its Capital

Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 14
Doximity, Inc.'s (NYSE:DOCS) Intrinsic Value Is Potentially 29% Above Its Share Price

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 30
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Sep 25
Doximity (NYSE:DOCS) Might Be Having Difficulty Using Its Capital Effectively

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Jul 29
A Look At The Intrinsic Value Of Doximity, Inc. (NYSE:DOCS)

Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Jul 09
Why Doximity, Inc. (NYSE:DOCS) Could Be Worth Watching

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

The Returns At Doximity (NYSE:DOCS) Aren't Growing

Jun 21
The Returns At Doximity (NYSE:DOCS) Aren't Growing

Doximity: Digital Health Play With Strong Fundamentals

Jun 21

A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Apr 07
A Look At The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Mar 20
Doximity (NYSE:DOCS) Is Reinvesting At Lower Rates Of Return

Doximity: Good Business But Extremely Overvalued

Feb 18

Doximity Q3 Earnings: Disappointing Results

Feb 10

Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Dec 25
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)

Doximity: On The Right Path To Further Consolidate Market Share

Dec 22

Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Dec 04
Here's What's Concerning About Doximity's (NYSE:DOCS) Returns On Capital

Doximity up 16% after fiscal 2023 Q2 beats, FY revenue range includes consensus

Nov 10

Doximity, down 9%, falls below IPO price

Oct 12

Doximity Appears Well-Positioned But Shares May Be Fully Valued Here

Aug 11

Doximity Non-GAAP EPS of $0.14 beats by $0.03, revenue of $90.6M beats by $0.95M

Aug 04

Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Jul 09
Unpleasant Surprises Could Be In Store For Doximity, Inc.'s (NYSE:DOCS) Shares

Pair Trade: Going Long Doximity And Short Teladoc

Jul 05

Doximity: Slowing Guidance, Stock Drops, But It Oozes Cash Flows

May 18

Doximity: Turning Bullish After Stock Price Correction

Apr 01

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jeff Tangney en comparación con los beneficios de Doximity?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

US$138m

Sep 30 2023n/an/a

US$123m

Jun 30 2023n/an/a

US$119m

Mar 31 2023US$244kUS$240k

US$113m

Dec 31 2022n/an/a

US$119m

Sep 30 2022n/an/a

US$141m

Jun 30 2022n/an/a

US$148m

Mar 31 2022US$243kUS$240k

US$133m

Dec 31 2021n/an/a

US$107m

Sep 30 2021n/an/a

US$57m

Jun 30 2021n/an/a

US$30m

Mar 31 2021US$21mUS$240k

US$22m

Compensación vs. Mercado: La compensación total de Jeff($USD243.73K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD6.57M).

Compensación vs. Ingresos: La compensación de Jeff ha sido consistente con los resultados de la empresa en el último año.

CEO

Jeff Tangney (50 yo)

14.1yrs

Permanencia

US$243,726

Compensación

Mr. Jeffrey A. Tangney, also known as Jeff, Co-Founded Doximity, Inc. in 2010 and has been its Chief Executive Officer and Director since April 2010 and serves as its Chairperson. Mr. Tangney also serves a...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Jeffrey Tangney
Co-Founder14.1yrsUS$243.73k27.22%
$ 1.2b
Nate Gross
Co-Founder & Chief Strategy Officerno dataUS$1.80m0.26%
$ 11.4m
Anna Bryson
Chief Financial Officer3.3yrsUS$453.71k0.075%
$ 3.3m
Jennifer Chaloemtiarana
General Counsel & Corporate Secretary3.8yrsUS$1.58m0.0032%
$ 140.8k
Paul Jorgensen
Chief Revenue Officer2.3yrsUS$455.14k0.11%
$ 4.9m
Shari Buck
Co-founder and SVP People & Opsno datasin datossin datos
Jey Balachandran
Chief Technology Officerno datasin datossin datos
Perry Gold
Head of Investor Relationsno datasin datossin datos
Jim Rivas
Head of Corporate Communicationsno datasin datossin datos
Bruno Miranda
Senior VP of Engineeringno datasin datossin datos
Joel Davis
SVP of Productno datasin datossin datos
Ben Greenberg
Senior Vice President of Commercial Productsless than a yearsin datossin datos

3.3yrs

Permanencia media

50yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DOCS se considera experimentado (3.2 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Jeffrey Tangney
Co-Founder14.1yrsUS$243.73k27.22%
$ 1.2b
Barry Chaiken
Member of Medical Advisory Boardno datasin datossin datos
Timothy Cabral
Independent Director3.7yrsUS$245.25k0.0025%
$ 112.7k
Kevin Spain
Independent Director13.2yrsUS$247.25k0.098%
$ 4.4m
Lawrence Chin
Member of Medical Advisory Boardno datasin datossin datos
Elise Brett
Member of Medical Advisory Boardno datasin datossin datos
Bradley Cohn
Member of Medical Advisory Boardno datasin datossin datos
Alexander Ding
Member of Medical Advisory Boardno datasin datossin datos
Sharon Drost
Member of Medical Advisory Boardno datasin datossin datos
Todd Ferris
Member of Medical Advisory Boardno datasin datossin datos
Harvey Fishman
Member of Medical Advisory Boardno datasin datossin datos
Kira Wampler
Independent Director4.2yrsUS$239.25k0.0025%
$ 112.7k

8.7yrs

Permanencia media

50.5yo

Promedio de edad

Junta con experiencia: La junta directiva de DOCS se considera experimentada (8.6 años de antigüedad promedio).